skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > dibenzooxazepine > arugosin p
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > dibenzooxazepine > arugosin p
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > dibenzooxazepine > arugosin p
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > dibenzooxazepine > arugosin p
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzooxazepine > arugosin p
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzooxazepine > arugosin p
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzooxazepine > arugosin p

Preferred term

arugosin p  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C33H42O8

inchi

  • InChI=1S/C33H42O8/c1-19(9-8-10-20(2)12-16-27(33(5,6)38)40-22(4)34)11-13-23-14-15-26-29(30(23)36)31(37)28-24(32(39-7)41-26)17-21(3)18-25(28)35/h10-11,14-15,17-18,27,32,35-36,38H,8-9,12-13,16H2,1-7H3/b19-11+,20-10+

inchikey

  • PDPCNBRIXHVERZ-CWGBCDKESA-N

mass

  • 566.691

monoisotopicmass

  • 566.28797

smiles

  • O=C1C2=C(O)C(=CC=C2OC(C=3C1=C(O)C=C(C)C3)OC)C/C=C(/CC/C=C(/CCC(OC(=O)C)C(O)(C)C)/C)/C

subset

  • 2_STAR

synonym EXACT

  • [(6E,10E)-12-(1,10-dihydroxy-6-methoxy-8-methyl-11-oxo-6H-benzo[c][1]benzoxepin-2-yl)-2-hydroxy-2,6,10-trimethyldodeca-6,10-dien-3-yl] acetate

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:211700

Download this concept:

RDF/XML TURTLE JSON-LD